4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001104659-21-129571
Options or other derivatives
- Director acquired 26,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ross Michael Jay Director | 2021-10-21 | Grant or award · Stock Option (right to buy) | +26,400 | 26,400 | D: show line 1 in the form |
Loading xslF345X03/tm2130646-22_4seq1.xml…